Taisho Pharmaceutical Holdings Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Taisho Pharmaceutical Holdings Co Ltd with three other
companies in this sector in Japan:
Santen Pharmaceutical Company Limited
sales of 234.03 billion Japanese Yen [US$2.16 billion]
of which 100%
was Pharmaceutical Products),
Ohki Healthcare Holdings Co Ltd
(258.48 billion Japanese Yen [US$2.38 billion]
of which 44%
was Drug), and
Ono Pharmaceutical Co Ltd
(288.63 billion Japanese Yen [US$2.66 billion]
of which 72%
was Products & Goods).
During the year ended March of 2019, sales at
Taisho Pharmaceutical Holdings Co Ltd were ¥261.55 billion (US$2.41 billion).
decrease of 6.6%
versus 2018, when the company's sales were ¥280.09 billion.
Contributing to the drop in overall sales was the 15.3% decline
in Medicine, from ¥96.10 billion to ¥81.43 billion.
There were also decreases in sales in
Self-Medication (down 2.1% to ¥180.12 billion)